Daiki Kojima
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Daiki Kojima has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
Kaori Hayashi
Division of Endocrinology, Metabolism and Nephrology, Department of Internal Medicine Keio University School of Medicine Tokyo Japan
4 shared publicationsHiroshi Itoh
Division of Endocrinology, Metabolism and Nephrology, Department of Internal Medicine Keio University School of Medicine Tokyo Japan
3 shared publicationsTakeshi Kanda
Division of Endocrinology, Metabolism and Nephrology, Department of Internal Medicine Keio University School of Medicine Tokyo Japan
3 shared publications- Jun Yoshino
Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Shimane University, Izumo, Japan
2 shared publications Kenji Kaneko
Division of Endocrinology, Metabolism and Nephrology, Department of Internal Medicine Keio University School of Medicine Tokyo Japan
2 shared publicationsRyunosuke Mitsuno
Division of Endocrinology, Metabolism and Nephrology, Department of Internal Medicine Keio University School of Medicine Tokyo Japan
2 shared publications
Latest Publications
- Open Access
- 29 September 2025
- Published by Wiley in Aging Cell
- Vol. 24 (11) , e70222
Vascular Endothelial NAMPT ‐Mediated NAD + Biosynthesis Regulates Angiogenesis and Cardiometabolic Functions in Male Mice
Aging is associated with metabolic dysfunction and cardiovascular abnormalities. Defective nicotinamide adenine dinucleotide (NAD + ) biosynthesis correlates with aging and aging‐associated complications. However, the precise molecular mechanisms linking aging‐associated NAD + deficiency to cardiometabolic dysfunction remain unclear. Herein, we examined whether nicotinamide phosphoribosyltransferase (NAMPT), a key enzyme in NAD + biosynthesis, influences vascular endothelial function and whole‐body metabolic and hemodynamic homeostasis during aging. Vascular endothelial cell–specific Nampt knockout (VeNKO) mice fed a regular chow diet exhibited no cardiometabolic abnormalities, whereas male VeNKO mice fed a high‐fat diet exhibited reduced angiogenesis, resulting in impaired subcutaneous adipogenesis, impaired glucose metabolism, and hemodynamic disturbances. Mechanistically, NAMPT loss attenuated NAD + ‐dependent deacetylase sirtuin‐1 (SIRT1) and endothelial nitric oxide synthase (eNOS) signaling, impairing angiogenesis. Aged mice exhibited endothelial NAD + depletion driven by an imbalance between NAMPT‐mediated NAD + biosynthesis and consumption, leading to impaired eNOS signaling and associated angiogenic and cardiometabolic dysfunction, similar to that observed in VeNKO mice. Nicotinamide mononucleotide administration replenished vascular endothelial NAD + levels, improved angiogenesis, restored subcutaneous adipose tissue volume, and ameliorated aging‐associated cardiometabolic dysfunction. Collectively, our findings provide mechanistic and therapeutic insights into vascular endothelial NAMPT–NAD + –SIRT1–eNOS signaling related to aging‐associated cardiometabolic disorders.
- 29 September 2025
- Published by Wiley in Aging Cell
- Vol. 24 (11) , e70222
Open AccessVascular Endothelial NAMPT ‐Mediated NAD + Biosynthesis Regulates Angiogenesis and Cardiometabolic Functions in Male Mice
Aging is associated with metabolic dysfunction and cardiovascular abnormalities. Defective nicotinamide adenine dinucleotide (NAD + ) biosynthesis correlates with aging and aging‐associated complications. However, the precise molecular mechanisms linking aging‐associated NAD + deficiency to cardiometabolic dysfunction remain unclear. Herein, we examined whether nicotinamide phosphoribosyltransferase (NAMPT), a key enzyme in NAD + biosynthesis, influences vascular endothelial function and whole‐body metabolic and hemodynamic homeostasis during aging. Vascular endothelial cell–specific Nampt knockout (VeNKO) mice fed a regular chow diet exhibited no cardiometabolic abnormalities, whereas male VeNKO mice fed a high‐fat diet exhibited reduced angiogenesis, resulting in impaired subcutaneous adipogenesis, impaired glucose metabolism, and hemodynamic disturbances. Mechanistically, NAMPT loss attenuated NAD + ‐dependent deacetylase sirtuin‐1 (SIRT1) and endothelial nitric oxide synthase (eNOS) signaling, impairing angiogenesis. Aged mice exhibited endothelial NAD + depletion driven by an imbalance between NAMPT‐mediated NAD + biosynthesis and consumption, leading to impaired eNOS signaling and associated angiogenic and cardiometabolic dysfunction, similar to that observed in VeNKO mice. Nicotinamide mononucleotide administration replenished vascular endothelial NAD + levels, improved angiogenesis, restored subcutaneous adipose tissue volume, and ameliorated aging‐associated cardiometabolic dysfunction. Collectively, our findings provide mechanistic and therapeutic insights into vascular endothelial NAMPT–NAD + –SIRT1–eNOS signaling related to aging‐associated cardiometabolic disorders.
- 1 July 2024
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 327 (1) , E81-E88
Adipocyte-specific inactivation of NAMPT, a key NAD+ biosynthetic enzyme, causes a metabolically unhealthy lean phenotype in female mice during aging
Defective NAD+ metabolism is associated with aging and age-associated metabolic diseases. In the present study, we provided in-depth metabolic assessments in female mice with adipocyte-specific inactivation of a key NAD+ biosynthetic enzyme NAMPT and revealed an unexpected role of adipose tissue NAMPT-NAD+-PPAR-γ axis in maintaining functional integrity and quantity of adipose tissue and whole body metabolic health during the aging process.
- 1 July 2024
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 327 (1) , E81-E88
Adipocyte-specific inactivation of NAMPT, a key NAD+ biosynthetic enzyme, causes a metabolically unhealthy lean phenotype in female mice during aging
Defective NAD+ metabolism is associated with aging and age-associated metabolic diseases. In the present study, we provided in-depth metabolic assessments in female mice with adipocyte-specific inactivation of a key NAD+ biosynthetic enzyme NAMPT and revealed an unexpected role of adipose tissue NAMPT-NAD+-PPAR-γ axis in maintaining functional integrity and quantity of adipose tissue and whole body metabolic health during the aging process.
- Open Access
- 22 June 2023
- Published by Wiley in Therapeutic Apheresis and Dialysis
- Vol. 27 (6) , 1103-1112
Clinical significance of serum urea‐to‐creatinine ratio in patients undergoing peritoneal dialysis
Introduction: We aimed to determine the correlation between the serum urea‐to‐creatinine ratio and residual kidney function (RKF) in patients undergoing peritoneal dialysis (PD), as well as its predictive value for PD‐related outcomes.Methods: This study included a cross‐sectional study to assess the correlation between serum urea‐to‐creatinine ratio and RKF in 50 patients on PD and a retrospective cohort study to assess the association between serum urea‐to‐creatinine ratio and PD‐related outcomes in 122 patients who initiated PD.Results: Serum urea‐to‐creatinine ratios had significant positive correlations with renal Kt/V and creatinine clearance values (r = 0.60, p < 0.001 and r = 0.61, p < 0.001, respectively). Additionally, serum urea‐to‐creatinine ratio was significantly associated with a lower risk of transfer to hemodialysis or PD/hemodialysis hybrid therapy (hazard ratio: 0.84, 95% confidence interval: 0.75–0.95).Conclusion: The serum urea‐to‐creatinine ratio can be an indicator of RKF and a prognostic factor in patients undergoing PD.
- 22 June 2023
- Published by Wiley in Therapeutic Apheresis and Dialysis
- Vol. 27 (6) , 1103-1112
Open AccessClinical significance of serum urea‐to‐creatinine ratio in patients undergoing peritoneal dialysis
Introduction: We aimed to determine the correlation between the serum urea‐to‐creatinine ratio and residual kidney function (RKF) in patients undergoing peritoneal dialysis (PD), as well as its predictive value for PD‐related outcomes.Methods: This study included a cross‐sectional study to assess the correlation between serum urea‐to‐creatinine ratio and RKF in 50 patients on PD and a retrospective cohort study to assess the association between serum urea‐to‐creatinine ratio and PD‐related outcomes in 122 patients who initiated PD.Results: Serum urea‐to‐creatinine ratios had significant positive correlations with renal Kt/V and creatinine clearance values (r = 0.60, p < 0.001 and r = 0.61, p < 0.001, respectively). Additionally, serum urea‐to‐creatinine ratio was significantly associated with a lower risk of transfer to hemodialysis or PD/hemodialysis hybrid therapy (hazard ratio: 0.84, 95% confidence interval: 0.75–0.95).Conclusion: The serum urea‐to‐creatinine ratio can be an indicator of RKF and a prognostic factor in patients undergoing PD.